Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study

Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study

Abstract Introduction Dolutegravir (DTG) is widely used for antiretroviral therapy (ART). We compared weight and blood pressure trends and examined the association between high blood pressure and weight gain among people living with HIV (PLHIV) switching to or starting DTG‐based, efavirenz (EFV)‐bas...

Full description

Bibliographic Details
Main Authors: Tinei Shamu, Matthias Egger, Tinashe Mudzviti, Cleophas Chimbetete, Justen Manasa, Nanina Anderegg
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Journal of the International AIDS Society
Subjects:
HIV
dolutegravir
blood pressure
hypertension
body weight
Zimbabwe
Online Access:https://doi.org/10.1002/jia2.26216

Internet

https://doi.org/10.1002/jia2.26216

Similar Items